The global active pharmaceutical ingredient (API) market is expected to grow at a CAGR of more than 8.0% from 2014 to 2019, according to Research and Markets1. Factors such as expiry of patented drugs and the shift towards the use of lower cost API drugs due to economic recession are driving growth in the API market. In addition, the rising use of highly potent actives in targeted therapies is boosting growth. However, the market faces challenges of transparency and increased market fragmentation, the report says.
展开▼
机译：根据Research and Markets1的预测，从2014年到2019年，全球活性药物成分（API）市场的复合年增长率将超过8.0％。专利药品到期以及由于经济衰退而转向使用低成本API药物等因素正在推动API市场的增长。此外，在靶向疗法中越来越多地使用强效活性物质正在促进增长。报告称，然而，市场面临透明度和市场分散化的挑战。
展开▼
